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ABBREVIATIONS 
 
ACN    Acetonitril  
ALS    Amyotrophic lateral sclerosis  
Arg   Arginine 
BBB   Blood brain barrier 
CME    Clathrin- mediated endocytosis  
CPPs   Cell Penetrating Peptides  
CvME    Caveolae–mediated endocytosis  
DA   Dopamin 
D-Arg   D-arginine  
DIC    1,3-diisopropylcarbodiimide 
DIPEA   N,N-Diisopropylethylamine  
DMEM    Dulbecco's Modified Eagle Medium 
DMF    Dimethylformamide  
DMSO     Dimethylsulfoxide 
DTT    Dithiolthreitol 
EDT    1, 2-Ethanedithiol 
EDTA   Ethylenediaminetetraacetic 
FAM   Carboxyfluorescein  
FCCP   Carbonyl cyanide 4-(trifluorometoxy)phenylhydrazone) 
FDRA     Friedreich’s Ataxia  
Fmoc     9-Fluorenylmethyloxycarbonyl  
GFP      Green fluorescent protein 




Marco Pirisinu, “Rational design and applications of a new Cell-penetrating Peptide 
targeting Mitochondria”. Tesi di Dottorato di ricerca in Neuroscienze XXVII ciclo. Univerità 
degli studi di Sassari 
GSH     Glutathione 
GSSG     Glutathione disulfide  
HOBt    N-hydroxybenzotriazole  
IMM    Inner mitochondria membrane  
IMS     Inner membrane space 
Lys   Lysine 
MALDI    Matrix-assisted desorption ionization 
MP    Macropinocytosis  
MPT    Mitochondrial permeability transition  
NAC      N-Acetyl-L-Cysteine  
NLS    Nuclear Localization Sequences 
NMP    N-Methyl-2-pyrrolidone 
NS    Nervous system 
OMM     Outer mitochondrial membrane 
PBS    Phosphate buffered saline 
PD     Parkinson's disease 
PMSF    Phenylmethanesulfonyl fluoride 
ROS     Reactive oxygen species  
RP-HPLC   Reversed phase-High-performance liquid chromatography 
SNpc    Substantia nigra pars compacta  
SOD     Superoxido dismutase 
SPPS     Sintesi peptidica in fase solida 
Tboc     Di-tert-butyl dicarbonate 
TFA     Trifluoroacetic acid 
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TMRE    Tetramethylrhodamine methyl ester 
TOF     Time of flight 
TPP+    Triprenylphosphonium ion 
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Cellular oxidative stress is implicated in a wide array of cellular dysfunctions that 
give rise to onset of clinical disorders as ischemia-reperfusion injury (Takizawa et al. 
2011); neurodegenerative disease (Aoun et al., 2013); diabetes; infiammatory 
diseases; drug induced toxicity (Rivas, 2010). Over the years, different antioxidant 
approaches has been assessed but most of them did not show appreciable positive 
effects. The cellular membrane is a stumbling-block hard to overcome for most of 
natural and synthetic antioxidants, because of that their applicability window were 
strongly restricted. The efficacy of any drugs or gene therapy is related to two 
properties: ability of crossing cellular membranes and delivering a bioactive 
molecule on a specific cellular organelle. The cellular membrane of eukaryotic cell 
acts as a buckler that protects the cell from unregulated flow of bioactive 
molecules, ions and unwanted substances, in this way cell regulates the internal 
environment. Small molecules are able to cross the cellular membrane on their own 
instead of the larger drugs that because of their physicochemical characteristics are 
not capable to get into the cells and they need a special “help” as a delivery system. 
Delivery system must be efficient, safe and healthy. Mainly, there are two kind of 
delivery system: viral and non viral (Lajoie et al., 2015). This tesis is about one of the 
most novel non viral delivery system: cell penetrating peptide (CPPs). CPPs are short 
peptides sequences consisting up to 30 amino acids able to cross the cellular 
membrane and transport bioactive cargo into cells in an efficient and non toxic way. 
These short peptides have a positive charge, they are amphipathic and show both 
hydrophilic and lipophilic properties. A major breakthrough on CPPs date back in 
1980s and early 1990s, when a series of short natural peptides sequences able 
efficiently cross the plasma membrane were identified (Green et al., 1988). Over 
the years more CPPs was discovered. Full length HIV-1 transcription transactivation 
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received a great deal of attention when their ability to cross cellular membrane and 
accumulate into cellular nucleus was demonstrated (Derossi et al., 1994). Those 
discoveries served like a cornerstone for a new subfield focused on the use of CPPs 
as molecular transporters: that was the beginning of molecular drug delivery 
strategy. Day by day, chemists and biochemists developed many variations of 
peptide structures in order to improve crossing activity, keeping low toxicity and 
immunogenic effects. As of today, hundreds of CPPs are available. They show 
different amino sequence, physicochemical properties and several mechanism of 
internalization. Some CPPs has been obtained from natural sequences (Vivès et al., 
1997), while others from artificial constructs engineered (Pujals et al., 2008) to 
keep and exalt the important features of the molecules designed by nature. The 
identification of cellular targets for treatment of different disease states required 
the development of an efficient system able to delivery drugs into a target of 
interest. Different cargoes can be conjugated to CPPs as fluorophores, small 
molecular drugs, larger cargoes such as oligonucleotides, plasmids or proteins 
(Fawell et al., 1994). Uptake and efficacy of several therapeutic compounds are 
improved by CPPs conjugation, opening new opportunities to study biological 
process and making the treatment of several diseases more controlled and less 
toxic. The key of success in delivery strategy it depends on delivering drugs into 
specific target associated with the onset of particular disorder. Several studies 
demonstrated the mitochondrial involvement in the occurrence or worsening of the 
most disabling diseases. In view of all this mitochondria are interesting intracellular 
target for drug delivery. Nowadays, nucleus and mitochondria are great targeted. 
Cellular nucleus is targeted by Nuclear Localization Sequences (NLS), short cationic 
sequences, 10 amino acids in length (Goldfarb et al., 1986). These sequences are 
widely used to achieve nuclear delivery for a variety of DNA damaging agents or 
nucleic acids for gene therapy (Cartier et al., 2002). NLS find in cancer disease 
treatment the most promising field of application. Between NLS, simian virus 40 
(SV40) showed high levels of cell permeability and low toxicity, for this reason has 
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therapy (Sing et al., 1998). This thesis is focused on mitochondrial targeting 
peptide. Mitochondrion is an organelle structurally discernable to the others 
cellular organelles being characterized by two membranes that underline pivotal 
cellular functions played by mitochondria. A lot of studies are focused on this 
organelle and it is of gaining attention in pharmaceutical and medical research since 
has been confirmed that it is involved in several diseases showing a great diversity 
of clinical appearance (Saraste, 1999). Literature shows several examples of CPPs 
targeting mitochondria, using artificial, rather than natural signal sequences 
(Mahon et al., 2007). Mitochondrion is an important target for drug therapy given 
its role in the pathology of cancer, neurodegenerative diseases, and others where 
reactive oxygen species are linked with pathological conditions (Dai et al., 2014). To 
date, the short SS peptide developed by Szeto and Schiller (Schiller et al., 2000) are 
the most promising mitochondria-targeted antioxidants. SS-compounds are 
tetrapeptides and have been designed alternating aromatic residues and basic 
amino acids (aromatic-cationic peptides). They are characterized by tyrosine (tyr) or 
dimethyltyrosine (Dmt) residues in order to increase antioxidant activity, the 
presence of D-amino-acid in either the first or second position minimizes 
aminopeptidase degradation and amidation of C-terminus to protect against 
hydrolysis (Szeto, 2006). The antioxidant action of SS peptides can be attributed to 
the Tyr or Dmt residues. The sequence position of the Tyr or Dmt residue is not 
important in scavenging ROS and reducing LDL oxidation (Zhao et al., 2004). All of 
SS peptides show 3+ net charge at physiologic pH and they can get into cells in an 
energy-independent non saturable manner. The uptake is really fast, several studies 
showed that SS-20 peptide is taken up into cells in less than 30 minutes (Zhao et al., 
2004). The SS peptides target preferentially the inner mitochondrial membrane, 
indeed they concentrate in mitochondria 1,000-fold more compared with the 
cytosolic concentration (Zhao et al., 2004). The mechanism of uptake into 
mitochondria is still unclear. SS-peptide probably make use of their own positive 
charge to get into mitochondria but a lot of studies have been showed that these 
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al., 2007). To date, SS peptides are the most important targeting mitochondria of all 
know CPPS, since they are potent in reducing intracellular ROS and as well as 
preventing cell death. The first part of this thesis will start from a short description 
of mitochondria, structure and underline hub role on cellular metabolism and 
functions, why is important to preserve the right functionality of this organelle and 
why it is a promising target for drug delivery. After that, CPPs and characteristics of 
most important CPPs targeting mitochondria will be discussed. The last part of the 
thesis will be focused on the synthesis and application of a new short antioxidant 
cell penetrating peptide targeting mitochondria, outlining its applicability on drug 
delivery strategy and on antioxidant treatments, obtained results and future 
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Mitochondria 
 
Organization and functions 
 
Mitochondria are located in the cytoplasm of eukaryotic cells and play a pivotal role 
in cellular metabolism. Mitochondrion is fundamental in the generation of 
metabolic energy and it is responsible for most of the useful energy derived. Into 
mitochondria, the breakdown of carbohydrates and fatty acids is converted to ATP 
by the process of oxidative phosphorylation. Mitochondria are the main organelle 
for the synthesis of ATP under normal aerobic condition. The last oxidation step for 
fats and carbohydrates takes place in the mitochondria. The complicated structure 
of mitochondria is fundamental to perform these functions. During oxidation of fats 
and glycolysis, electrons are transferred from bioenergetic substrates to 
nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD). 
The high energy electron reduced forms, NADH and FADH2, is processed by a 
complex carrier system called electron chain reaction (ETC) (Cooper, 2000). Briefly, 
two electrons and two protons combine with ½ O2 to produce H2O. In the same 
time, protons are pumped from the mitochondrial matrix into inner membrane 
space (IMS) generating potential energy across the membrane, which is used to 
drive ATP synthesis. In short, all mitochondrial compartments are involved in ATP 
synthesis through a complex multistep process. In addition to this critical metabolic 
role mitochondria store calcium for cell signaling activities, generate heat, mediate 
cellular growth and death (Scheffler, 1999). Both number and size of mitochondria 
varies widely by organism and tissue type, but usually size range from 0.5 to 10μm 
and number range from a few hundreds to thousands each cell, it depending on 
both of the energy demands and cell type (Scheffler, 1999). Organization and 
function of mitochondria is widely studied. Mitochondria are rod-shaped, 
surrounded by double membrane, it consisting of four distinct compartments: the 
outer mitochondrial membrane (OMM), the inner membrane space (IMS), the inner 




Marco Pirisinu, “Rational design and applications of a new Cell-penetrating Peptide 
targeting Mitochondria”. Tesi di Dottorato di ricerca in Neuroscienze XXVII ciclo. Univerità 
degli studi di Sassari 
components plays distinct functional roles. IMM separates the mitochondrial matrix 
from the intermembrane space, it forms numerous folds (cristae) that extend into 
the interior (or matrix) of the organelle (Fig. 1). The cristae greatly increase the total 
surface area of the IMM. The IMM includes all the most important complexes that 
mitochondria need to fulfil their functions: all the complexes of the electron 
transport system, the ATP synthetase complex and transport proteins complex. The 
IMS is the smallest component of mitochondrion and it is located between the IMM 
and OMM. The IMS provides a redox active space, necessary environment to oxidize 
metabolic residues (Riemer, 2011). The IMS can exchange proteins, lipids, metal 
ions, and various metabolites with other cellular compartments, as OMM, allowing 
mitochondrial metabolism to adapt to cellular homeostasis. In particular, the 
biogenesis and activity of the respiratory chain is controlled by various proteins of 
the IMS (Vögtle, 2012). OMM is in direct contact with cellular cytoplasm. OMM is 
freely permeable to small molecules and contains special protein called porin that 
form channels allowing the free diffusion of molecules smaller than 6000 Daltons 
(Lin et al., 2014). OMM shows enzymes involved in the elongation of fatty acids, 
oxidation of epinephrine (adrenaline), and the degradation of tryptophan. Latest 
studies showed that apoptosis, longevity control are regulated by protein of OMM 
(Ran, 2014). The mitochondrial matrix is the space between cristae. The matrix 
contains the mitochondrial genetic system as well as the enzymes responsible for 
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Fig. 1. Mitohondrial structure. Adapted from Freitas Jr., Basic Capabilities, Landes Bioscience, Austin, Tex, USA, 1999 
 
Mitochondrial electron transport chain 
 
Mitochondrial electron transport chain is bound to inner mitochondrial membrane 
and mainly consists of five complexes called Complexes I through V (Fig. 2). 
Complex I, called also NADH-ubiquinone oxidoreductase, transports two electrons 
from NADH to the mitochondrial matrix and to coenzyme Q within the membrane. 
Complex I accepts electrons from NADH and it acts like a bridge between glycolysis, 
tricarboxylic acid cycle (TCA), fatty acid oxidation, and electron transport chain. Its 
complete structure is not been totally understood, our knowledge of the structure 
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or boot, can be dissociated in two sub-complexes knows as sub-complexes 1α and 
sub-complexes 1β, containing 23 and 17 subunits respectively (Grigorieff, 1999). 
The ankle of “boot” is thought to protrude from the membrane so as to be 
predominant in the aqueous phase and contains the binding site for NAD(H) and the 
input electron transfer chain. The foot (the hydrophobic protein) is membrane-
linked. Many inhibitors and several iron sulfur centers are localized on it as well as  
a catalytic site where reduction of ubiquinone occurs. Many disease conditions are 
associated to this complex, including leber hereditary optic neurophaty, melas 
syndrome, Altzheimer‘s disease and Parkinson’s disease (Meyers, 2013. Gaweda-
Walerych, 2013). 
Complex II, also known as succinate-coenzyme Q reductase or succinate 
dehydrogenase, is the only membrane-bound component of the Krebs cycle and in 
addition functions as a member of the electron transport chain in mitochondria and 
in many bacteria (Cecchini, 2003). Complex II acts as link between the TCA and 
electron transport chain. It is the only TCA cycle enzyme that is an integral 
membrane protein. Complex II oxidizes succinate to fumarate reducing FAD to 
FADH2. The structure of complex II is well investigated, has a mass of 124 kD and 
composed of two hydrophilic subunits, a flavoprotein and an iron-sulfur protein, 
and two hydrophobic subunits linked to membrane. 
Complex III, also named Cytochrome reductase, is a multisubunit transmembrane 
protein acceptor of electrons from reduced Coenzyme Q and uses them to reduce 
the second mobile electron carrier Cytochrome C. For each coenzyme Q fully 
oxidized, complex III moves four hydrogen ions outward from the matrix to the 
mitochondrial intermembrane space (Bolsover, 2011). 
Complex IV, or Cytochrome C oxydase, is the terminal enzyme of the respiratory 
chain. It is a transmembrane protein and consists of 13 polypeptide subunits, 3 of 
which are encoded by mitochondrial DNA. The Complex IV moves an electron from 
each of four Cytochrome C and reduces one oxygen molecule to two molecule of 
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contributing to generate a differential transmembrane difference of proton that the 
ATP synthase will use to synthesize ATP. 
ATP synthase, called also complex V, catalyzes ATP-Pi exchange, and ATP, GTP, and 
ITP hydrolysis. The synthesis of ATP from ADP and phosphate is driven across the 
membrane by a flux of protons gradient generated by IMS electron transfer 
(Galante et al., 1979). The ATP synthase catalyses a reversible reaction for this 




Fig. 2. Electron transport chain and ATP synthesis on the mitochondria inner membrane. Adapted from Szeto H.H. The AAPS 
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Mitochondrial Membrane Potential 
 
The optimum mitochondrial membrane potential (ΔΨm) is critical for preserving 
important cellular functions and mitochondrial processes as well keeping the 
physiological function of respiratory chain. The Δψm controls ATP synthesis, 
generation of ROS, mitochondrial calcium sequestration, import of proteins into the 
mitochondrion and mitochondrial membrane dynamics (Dai et al., 2014). 
Conversely, Δψm is controlled by ATP utilization, mitochondrial proton 
conductance, respiratory chain capacity and mitochondrial calcium. Depolarization 
might be found in oxidative stress conditions as consequence of mitochondrial 
calcium overload (Joshi et al., 2011). A significant loss of ΔΨm renders cells 
depleted of energy with subsequent increased mitochondrial membrane 
permeability. Hyperpolarization might be related to ATPase inhibition, inadequate 
supply of ADP, increased supply of NADH and apoptosis due to oxidative stress. The 
most used method for driving compound to mitochondria uses of the potential 
gradient across the mitochondrial inner membrane. As a result of moving proton 
and electron through mitochondrial electron transport complexes, a negative 
potential from 150 to 180 mV is generated across the IMM. Lipophilic cations may 
therefore accumulate 100-to 1000-fold in the mitochondrial matrix. A number of 
studies showed increased uptake into mitochondria in TPP+ and VitE -conjugated 
lipophilic sequence (Murphi et al., 2000. Jauslin et al., 2003). The uptake failed in 
depolarized mitochondrial membrane potential (Dhanasekaran et al., 2004), 
because of that the utility of TPP+-conjugated antioxidants is limited in model of 
neurodegenerative disease where mitochondrial membrane potential is impaired. 
To overcoming this problem in 2004 a new class of small cell permeable peptide 
antioxidants targeting mitochondria was described by Zhao and coworkers (Zhao et 
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Mitochondrial generation of ROS 
 
Mitochondria are small cellular organelle but consume around 85% of cellular 
oxygen to run the oxidative phosphorylation. As a consequence of mitochondrial 
metabolism, around 2% of oxygen is turned on superoxide anion (O2
-) (Chance, 
1979). The amount of O2
- production is subordinated to mitochondrial metabolic 
state and mitochondrial potential. Superoxide anion is not able to cross cellular 
membranes, but is converted to hydrogen peroxide (H2O2) by mitochondrial matrix 
enzyme MnSOD or by CuZnSOD in the intermembrane space. H2O2 is more stable 
than O2
¯ and can diffuse out of the mitochondria into the cytosol (Szeto, 2006). 
H2O2 can be readily converted on water by mitochondrial glutathione peroxidase or 
catalase. Moreover, H2O2 can reacts with ferrous iron and resulting, through 
Fentom reaction, in highly reactive hydroxyl radicals (OH•). As discussed above 
mitochondria are a major source of reactive oxygen species and superoxide is 
constantly generated during normal respiration by healthy mitochondria. Complex I, 
Complex II and Complex III are mainly involved in ROS production. Complex I 
transfers electrons from NADH to coenzyme Q, at the same time protons pass from 
the matrix to the intermembrane space and the anion superoxide is generated 
during movement of charge by complex I. Complex II reduces Coenzyme Q and is 
also responsible for production of low levels of superoxide anion. Complex III is 
responsible for increased ROS production in a state of decreased electrons transfer. 
In 1966, Jensen and colleagues understood the pivotal role mitochondria in ROS 
producing (Jensen, 1976), but to date, in spite of great knowledge of mitochondrial 
metabolism, a lot of pathway are still unclear. It is important to understand that 
ROS production is inevitable and useful process. Many studies showed the 
implication of ROS in important cellular pathway such as autophagy, signal 
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Mitochondrial Antioxidants 
Excess of ROS can be highly dangerous and damage cellular components as protein, 
lipid and DNA, leading to death of cell. Mitochondria and cells in general posses 
different defense system to avoid excess of ROS. These antioxidant network system 
can be rated as enzymatic (superoxide dismutase, catalase) or non enzymatic 
systems (glutathione).  
Superoxide Dismutase (SOD) is widely spread between living organism. All oxygen-
metabolizing cells (Gregory, 1974), many anaerobic bacteria (Hewitt, 1975) also 
fungi (Rapp, 1973) own SOD able to run the dismutation of superoxide radical to 
H2O2. Superoxide is converted to hydrogen peroxide (H2O2) by two types of 
intracellular superoxide dismutase (SOD) under physiological conditions: Cu/Zn-SOD 
in the cytosol and Mn-SOD in the mitochondrial matrix. Subsequently, the produced 
H2O2 is catalyzed into water and molecular oxygen by catalase or gluthatione 
peroxidase (GPx)  
2 O2¯+ 2H+ → O2+ H2O2 
Catalase (CAT, oxidoreductase, EC1.11.1.6) is an enzyme found in all aerobic 
organism and some anaerobic organisms (Brioukhanov et al., 2006). Catalase is 
located in cellular and subcellular compartements (Roels, 1976) and in 
mitochondria matrix (Radi, 1991).The primary function of catalase enzymes is the 
rapid breakdown of hydrogen peroxide into water and safe oxygen. 
2 H2O2 → 2 H2O + O2 
Glutathione (L-y-glutamyl-L-cysteinyl-glycine; GSH,) is a tripeptide synthesized in 
cytosol. Cysteine and glycine are linked by peptide bond and the carboxyl group of 
the glutamate side-chain to the amine group of cysteine by gamma peptide linkage. 
Glutathione has been discovered in animals, plants and fungi (Penninckx, 2000) and 
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H2O2 and reactive nitrogen species (RNS), it is involved in many cellular functions as 
cell signaling, protein function, gene expression, cell differentiation/Proliferation, 
and its depletion is correlated with many disease as neurodegenerative disease. 
GSH is not required by diet but every cells of animal organism can synthesize it, so 
GSH is distributed overall the human body and levels vary according to organs and 
tissues and subcellular compartments (Wu, 2004). GSH is synthesized in the cytosol 
then delivered in different cellular compartments; 12% of total cellular GSH is 
located in mitochondria. The antioxidant action of molecule of GSH is related to 
thiol groups of cysteine by serving as an electron donor. In presence of H2O2, GSH is 
oxidized by Glutathione peroxidase (GPx) to GSH disulfide (GSSG), which is then 
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Oxidative stress  
 
Generation of ROS is a physiological consequence of cellular metabolism and useful 
tool to different biological pathways. Cells own different antioxidant systems in 
order to maintain right concentration of ROS. The physiological production of ROS is 
not dangerous, but a spatiotemporal imbalance between ROS production and ROS 
defense systems the starting point of cellular impairments. The reduction of 
antioxidant systems lets to oxidation of membrane phospholipids, proteins, and 
nucleic acids and this condition, named oxidative stress, can lead to necrotic or 
apoptosis cellular death (Zamzami et al., 1997). Oxidative stress has been 
associated to many diseases, including cancer, renal disease, neurodegenerative 
and cardiovascular disease (Hroudová 2014). Several studies showed increased 
levels of ROS in diabetes type 1 and type 2. At the moment, the relations between 
increased ROS and diabetes is not clear but seems that high level of reactive species 
of oxygen contribute to insulin resistance, the basis of diabetes (Rösen, 2001). 
Mitochondria are the major site of ROS, generated as byproducts of the electron 
transport chain. Moreover, mitochondria are continuously exposed to ROS and 
because of that particularly susceptible to oxidative damage. Mitochondrial DNA 
has been shown to undergo oxidative damage. In addition to lipid peroxidation, 
protein oxidation and nitration results in altered function of many metabolic 
enzymes in the mitochondrial matrix as well as in the electron transport chain. A 
particularly relevant protein that loses function upon oxidation is SOD, which would 
further compromise antioxidant capacity and lead to further oxidative stress (Szeto, 
2006). In addition, the excess of ROS seems to be involved in cytochrome C release 
from mitochondria. Cytochrome C is normally bound to the inner mitochondrial 
membrane linked to cardiolipin. Cytocrom C participates supporting function of ATP 
synthesis. High levels of ROS lead to peroxidation of cardiolipin, then to the 
dissociation of Cytochrome C release through the OMM into the cytosol. 
Cytochrome C in the cytoplasm triggers the activation of caspase-9, which triggers 
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critical regulators of cell death and a key feature of neurodegeneration, and they 
play important role in cell processes, signaling pathways, calcium homeostasis, cell 
cycle regulation, apoptosis, ROS production, and thermogenesis rendering this 
organelle an important target for the delivery of radical scavengers. Achieving 
successful mitochondrial drug delivery could produce enhanced treatments for 
mitochondria-related disorders and also advance our knowledge of the roles that 






Marco Pirisinu, “Rational design and applications of a new Cell-penetrating Peptide 
targeting Mitochondria”. Tesi di Dottorato di ricerca in Neuroscienze XXVII ciclo. Univerità 





Over the last two decades, many different short peptide sequences able to 
transport diverse types of cargo molecules across cellular membrane have been 
identified. The continuous development of this field indicates that chemical space is 
rich in peptide sequences that exhibit high levels of cellular uptake. There are 
different ways to classify CPPs, on according to their origin, such as their charge, 
function, hydrophobicity or amphypathicity. One way to classify is to subdivide 
them into protein-derived, chimeric and synthetic or designed CPPs (Table. 1). 
 
Protein–derived CPPs were the first type of CPPs discovered, Penetratin and Tat 
belong to this category. The basic domain of HIV-Tat, which is sufficient for cell 
penetration, and the penetratin peptide, residues 43–58 derived from the third 
helix of Antennapedia protein homeodomain from Drosophila, are arguably the 
most studied CPPs. Both of them are still being used to this date and have in many 
cases been further modified to obtain new CPPs (Saleh et al., 2010). 
Synthetic CPPs are entirely designed, this class ranges from simple polypeptides 
such as poly–argynine (Futaki et al., 2007) to more complicated synthetic 
sequences including the model amphipatic peptide (Oehlke et al., 1998). Synthetic 
CPPs are still less common than protein derived or chimeric CPPs. 
Chimeric CPPs are combinations of protein–derived and synthetic sequences. 
Transportan is typical examples of chimeric CPPs. Transportan is a 27 amino acid-
long peptide. The sequence of Transportan was designed using the natural amino 
terminus of the neuropeptide Galanin and the carboxyl terminus of Mastoparan by 
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CPPs Origin Sequence Ref. 
Tat HIV-1transactivator protein GRKKRRQRRRPPQ Vivès et al.1997 
EB1 Chimeric LIRLWSHLIHIWFQNRRLWKKK Lundberg et al. 2007 
SAP Designed VRLPPPVRLPPPVRLPPP Pujals et al. 2008 
R9 Designed RRRRRRRRR Futaki et al.2001  
TABLE 1. Example of common CPP by classification 
 
CPPs uptake mechanism 
 
A numbers of investigations have been conducted to elucidate how CPPs get into 
the cells (Duchardt et al., 2007). Most of naked peptides CPPs use endocytosis 
mechanism but a variety of uptake mechanisms appear to be operative in different 
systems, and in some cases, the mechanism is cell-type or cargo-specific (Mueller et 
al., 2008). For example, in 2003, Fittipaldi and coworkes showed that TAT uses a 
lipid raft mediated endocytosis when conjugated to a protein (Fittipaldi et al., 
2003) and clathrin–dependent endocytosis if conjugated to a fluorophore (Richard 
et al., 2005). The uptake mechanism was initially considered direct, non–endocytic 
and receptor independent, but later studies showed CPPs can access the cell by two 
distinct routes: energy-dependent vesicular mechanisms, collectively referred to as 
endocytosis, or via a direct process involving translocation of the lipid bilayer, 
especially at high concentrations of peptide, also the same peptide can be taken via 
endocytic and direct pathways (Fig.3) (Duchardt et al., 2007). 
 
Endocytosis 
Endocytic mechanism is an energy dependent form of cellular uptake, is a regulated 
process used by cells to internalize solutes and fluids in the extracellular matrix 
(Yamada et al., 2008). This mechanism is run by interactions between peptide and 
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phospholipids. In addition, when linked to larger cargos, CPPs can utilize certain 
receptors in order to improve their uptake, such as class A scavenger receptors 
(Lindberg et al., 2013). Endocytosis is commonly divided in phagocytosis and 
pinocytosis. Phagocytosis has generally not been associated with CPPs and is 
reserved only for specialized cells, such as macrophages, monocytes, dendritic cells 
and neutrophiles; is a complex process used to engulf large particles (Aderem et al., 
1999) such as bacteria or dead cells, it has been recently shown that a phagocytic 
process occurs in particles larger than 0.5 µm and is influenced by particle shape 
(Aderem et al., 1999). 
Pinocytosis can be further classified in diverse pathways: clathrin-mediated 
endocytosis (CME), caveolae–mediated endocytosis (CvME), macropinocytosis 
(MP), clathrin and caveolin independent endocytosis (Hillaireau et al., 2009). 
Pinocytosis occurs in all cell types. The exact mechanisms of each of these pinocytic 
processes differ with regard to vesicle structure and the protein machinery utilized, 
they all share a common outcome: extracellular molecules are encapsulated into 
lipid vesicles, which are internalized after resealing of the plasma membrane.  
Clathrin-mediated endocytosis 
CME is the most well studied endocytic pathway. This mechanism starts with 
formation of vesicles, size around 100-150 nm in diameter and coated with a 
complex of proteins mainly consisting of clathrin. Vesicles are formed in specialized 
regions of the plasma membrane called clathrin coated pills. The mechanism of 
their formation is characterized by several steps. Primarily, the enzyme GTPase 
dynamin drives the invagination of the plasma membrane, as the invagination gets 
deeper turns in vesicles (Takey et al., 2001). Afterwards, endocytosed vesicles 
move from the surface of plasma membrane to deeper region of cell, during 
moving, vesicles turn into endosomes, pH around 6, to lysosomes, pH around 5, 
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Caveolae–mediated endocytosis 
CvME, also called as lipid raft-mediated endocytosis, is a cholesterol, dynamin-
dependent and receptor-mediated pathway (Nichols, 2003). It is characterized by 
endosomes formed from non-clathrin coated plasma membrane but consists of 
thecholesterol-binding protein caveolin and a cholesterol and glycolipid bi-layer. 
The fission of the caveolae from membranes is run by dynamin. Caveolae are 
approximately 50–80 nm in diameter. Their composition and function are highly 
cell-type dependent. Caveosomes are not degraded by acidic pH, therefore the 
cargo can be directly driven to the Golgi and/or endoplasmatic reticulum, avoiding 
normal lysosomal degradation (Bengali et al., 2007).  
Macropinocytosis 
MP is a mechanism of uptake able to take relatively large amounts of non-specific 
substances. MP usually occurs in macrophages and cancer cells, it is characterized 
by formation of actin–driven membrane protrusions which collapse into and fuse 
with the plasma membrane (Hillaireau et al., 2009). The size of vesicles, called 
macropinosomes, is around 200 nm-5 µm in diameter. The fate of macropinosomes 
is still unclear and seems to be cell type dependent. Futaki and colleagues reported 
arginine-rich CPPs are preferentially taken by the cells via macropinocitosis (Futaki 
et al., 2007). 
Clathrin and caveolin independent endocytosis 
This pathway is less studied than the others mechanism of uptake. Endocytosis 
occurs in cells depleted of both CME events and caveolin in cholesterol dependent 
manner, implying distinct endocytic pathways that require specific lipid 
compositions for internalization (Doherty et al., 2009). Clathrin and caveolin 
independent endocytosis can be further divided into dynamin-dependent and 
independent routes. The formed vesicles have different size, heterogeneous shape 
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Direct translocation 
Latest studies suggest that the translocation of polycationic CPPs across biological 
membranes occurred via an energy-independent cellular process, controlled by 
cholesterol and membranous protein (Pae et al., 2014). Direct translocation is 
characterized by destabilization of cellular membrane in an energy and 
temperature-independent manner (Bechara et al., 2013). Different models have 
been proposed to explain this kind of mechanism: inverted micelle formation, 
adaptive translocation and pore formation. Inverted micelle formation starts with 
an intussusception of cellular membrane due an electrostatic interactions and 
subsequent interaction of hydrophobic residues with the membrane core. Micelle 
origin from reorganization of neighbouring lipids at cellular surface, CPP is 
encapsulated by micelle and will be release inside after disruption of micelle 
(Derossi et al., 2002). Adaptive translocation seems to be exclusive for arginine-rich 
CPPs. Guanidium groups of arginines form bidentate hydrogen bonds with the 
phospholipid headgroups on the cell membrane: in this way CPPs get inside the cell. 
The pore formation model allows the passive diffusion of CPPs across the plasma 
membrane. This mechanism of uptake is mainly used by arginine and lysine rich 
CPPs. The attraction between the side chain of amino acid and the phospholipid 
headgroups of the distal layer leads to the formation of a transient pore (Morciano 
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CPPs in drug delivery strategy: Applications and organelle specific 
delivery  
Identification of cellular targets for treatment of different diseases required the 
development of a successful system able to delivery drugs into a target of interest. 
Some therapeutics exhibited excellent properties on in vitro studies, on the other 
hand on in vivo model the utilization was limited by their physicochemical 
characteristics. Uptake and efficacy of several therapeutic compounds are improved 
by CPPs conjugation, creating new opportunity to study biological process and 
making the treatment of several diseases more controlled, less toxic (Veldhoen et 
al. 2006). Different cargoes such as small molecules, imaging agents (Rao et al. 
2007), small molecular drugs and larger cargoes such as oligonucleotides (Meade et 
al. 2007), plasmids and protein (Morris et al. 2001) can be conjugated to CPPs 
(Fawell et al.. 1994) (Fig.4). CPPs are actually one of the most important biological 
tools used to delivery drugs inside specific cellular organelle. 
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Nuclear Localization Sequences 
Signal peptides are an effective strategy for organelle-specific targeting, used by 
cellular machinery to identify newly translated peptides and traffic them to the 
correct destination in the cell. As the storehouse of genomic DNA, the nucleus is a 
desirable target and the necessary destination for agents used in gene therapy 
(Cartier et al., 2002). Between Nuclear Localization Sequences (NLS) are cellular 
penetrating peptides targeting nucleus. These short cationic sequences, 10 amino 
acids in length, are widely used to achieve nuclear delivery for a variety of DNA 
damaging agents or nucleic acids for gene therapy (Cartier et al., 2002), between 
NLS, Simian virus 40 (SV40) showed high levels of cell permeability and low toxicity, 
because of that has been applied in a lot of studies to drive uptake of DNA in 
nonviral gene therapy (Singh et al., 1998). Other strategy adopted to delivery DNA 
inside the nucleus is encapsulating in polymer nanospheres or phage particles with 
NLS peptide displayed on the exterior (Akuta et al., 2002). L. Benimetskaya and coll. 
used NLS to delivery Antisense oligonucleotides and block translation of Bcl-2 and 
Fig.4. Applications of cell-penetrating peptidies as molecular devilery machine. Modified from 
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PKC-a in prostate and bladder carcinoma cells (Benimetskaya et al., 2002). Gold 
nanoparticles, carboplatin-based anti-cancer therapeutics, and green fluorescent 
protein (GFP) can be driven and localized inside the nucleus by NLS (Tkachenko et 
al., 2003. Wagstaff et al., 2007). At today, many studies show an improvement in 




Literature shows several examples of CPPs targeting mitochondria, using artificial, 
rather than natural signal sequences (Mahon et al., 2007). Mitochondrion is an 
important target of drug therapy due to its role in the pathology of cancer, 
neurodegenerative diseases and other diseases dealing with reactive oxygen 
species. Oxidative stress is the beginning or a consequence of several pathological 
conditions. Mitochondria are often the organelles where oxidative stress starts or 
main target of oxidative stress, therefore the mitochondrion represents candidate 
of significant interest for organelle-specific exogenous molecules. Hindering 
oxidative stress with delivering of antioxidant has been found to be effective in 
many animal models of diseases associated with oxidative damage (Chao, 2014. 
Kim, 2014). Sometimes, administration of antioxidants have exacerbated the 
oxidative condition instead of leading to significant benefits, this conflicting action is 
named antioxidant paradox (Halliwell, 2000). Some antioxidants beside their 
antioxidant action can have a prooxidant action especially in the presence of metals 
such as iron (Fe) which starts Fenton reaction (Murakami et al., 2007). High hopes 
and expectations in vitro about promising antioxidants have turned into delusions 
when the same results were not obtained in vivo studies. Up to now, there are 
literally dozens of completed or ongoing clinical trials using such antioxidants as 
vitamin E, epigallocatechin gallate (EGCG), resveratrol, curcumin, pramipexole, 
latrepirdine, ubiquinone, lipoic acid, idebenone, Ginkgo biloba, and N-acetylcysteine 
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positive results, since several showed a negative association between antioxidant 
supplementation and positive outcomes. A significant challenge to mitochondrial 
drug delivery is the impervious structure of the hydrophobic inner membrane. 
Some antioxidants do not penetrate cellular or mitochondrial membranes therefore 
they are not effective against intracellular ROS, others are very lipophilic and tend 
to be retained in cell membranes (Dixon et al. 2007). Many efforts have been done 
in order to develop an ideal antioxidant and there is still a long way to go and crucial 
questions remain to be answered. Does the “ideal” antioxidant really exist? Several 
research groups are looking for this answer. The ideal antioxidant should be cell-
permeable and able to target mitochondria therefore it can protect against 
oxidative damage and prevent mitochondrial impairmet. Latest results showed that 
two properties are important for passage across both the plasma and mitochondrial 
membranes: positive charge takes advantage of the potential gradient to get into 
mitochondria, lipophilic character in order to allow partitioning of the molecule 
through the lipid bilayer (Rosania et al., 2003). 
 
TPP+-conjugated  
Several mitochondria-targeted antioxidants have been developed and are currently 
undergoing preclinical testing. In the past, the most common strategies used for 
delivering compounds into mitochondria have relied on the conjugation of known 
redox agents to triprenylphosphonium ion (TPP+) (Adlam et al., 2005). It is an 
example of a cationic hydrophobic molecule with delocalized charge that can cross 
the mitochondrial membrane without a transporter. Another strategy is aromatic-
cationic tetrapeptides that selectively target the inner mitochondrial membrane 
without relying on mitochondrial potential. TPP+ has been conjugated to lipophilic 
antioxidants such as coenzyme Q (MitoQ) (Skulachev et al., 2009), plastoquirone 
(SkQ1) (Smith et al., 2012) and Vitamin E (MitoVitE) (Murphy et al.,2000. Sheu et 
al., 2006). They showed an increased uptake in comparison to the same molecule 
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reduced thiols, and reducing oxidative cell death (Kelso et al., 2001). In particular, 
MitoVitE was reported to be 800-fold more potent than idebenone protecting 
against GSH depletion in cultured fibroblast from patients with Friedreich’s Ataxia 
(FDRA). Furthermore, MitoVitE is 350-fold more potent than trolox (water soluble 
Vitamin E analog) (Szeto, 2006). Intraperitoneal and intravenous administrations of 
TPP+ were used in mice and the times of uptake and distribution were controversial. 
Uptake was obtained in the liver 1 hour after intraperitoneal injection, but was not 
detected in the brain and in the heart after 20 hours. TPP+ conjugated to MitoVitE 
was detectable in the heart 4 days after administration while levels in the brain 
were still really low (Smith et al., 2003). These TPP+-conjugated were evaluated on 
ischemia-reperfusion injury but not yet on models of neurodegenerative diseases. 
The utility and applicability of TPP+ is also limited by their mechanism of uptake. 
They need a normal mitochondrial potential to get this organelle, but all the 
neurodegenerative diseases are associated with abnormal mitochondrial potential. 
Furthermore, study on isolate mitochondria demonstrated that concentrations of 
TPP+ greater than 20 µM lead to wasting of IMM potential (Smith et al., 1999). 
 
Choline Esters of Glutathione and N-Acetyl-Cysteine 
Glutathione is a tripeptide (L-γ-glutamyl-L-cysteinyl-glycine) with strong antioxidant 
activity, detoxifying ROS and preventing thiol oxidation. Mitochondria are not 
capable to synthesize glutathione. The synthesis of glutathione occurs in the 
cytoplasm and transported into mitochondria by dicarboxylate and 2-oxoglutarate 
carriers (Chen et al., 2008). N-Acetyl-L-Cysteine (NAC) arises from the amino acid L-
cysteine, it exhibits antioxidant activity (Xue et al., 2011. Reliene et al., 2004) as 
well is also used to provide cysteine for glutathione synthesis. Both of them are 
really useful in protecting mitochondria against oxidative damage. Using the same 
approach as TPP+-conjugated described above, Sheu and co-workers prepared 
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NAC into mitochondria (Sheu et al., 2005). These compounds make use the 
negative internal potential of mitochondria, which leads and regulates their 
concentration in mitochondria. Ester of Glutathione is a membrane/lipid permeable 
derivative of GSH that is used to restore the GSH pool within cells subjected to 
cysteine and/or GSH depletion. Preliminary in vitro studies demonstrated that they 
are able to avoid depolarization due to hydrogen peroxide in neonatal rat 
ventricular myocytes and striatal neurons, but to date but in vivo animal studies are 
not yet accessible (Szeto et al., 2006). 
 
Szeto-Schiller Peptides 
Date back in 2000, synthesis of the short Szeto-Schiller peptides (SS-peptides), the 
most promising mitochondria-targeted antioxidant peptide (Schiller et al., 2000). 
The Szeto-Schiller (SS) compounds are tetrapeptides (Fig. 5) designed for 
alternating aromatic residues and basic amino acids (aromatic-cationic peptides), 
they are characterized by tyrosine (tyr) or dimethyltyrosine (Dmt) residues in order 
to increase antioxidant activity and the presence of D-amino-acid in either the first 
or second position to minimize aminopeptidase degradation, amidation of C-
terminus to reduce hydrolysis from C-terminus (Schiller, 2006). Scavenge activity of 
SS-peptides was proved first in vitro using luminol chemiluminescence, then 
antioxidant properties of SS-peptides were further established by inhibition of fatty 
acid peroxidation and low density lipoprotein (LDL) oxidation (Zhao et al., 2004). 
The antioxidant action of SS-peptides is dose dependent manner and can be 
attributed to Tyr or Dmt residues can scavenge H2O2, OH
. and ONOO.. The sequence 
position of the Tyr or Dmt residue is not important in scavenging ROS and inhibiting 
LDL oxidation but replacement of Dmt with phenylalanine (Phe) resulted in 
complete loss of antioxidant activity (Zhao, 2004). Tyr, or Dmt, can scavenge 
oxyradicals forming relatively unreactive tyrosyl radicals, which can be followed by 
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hydroperoxide (Hazel et al., 2006). Dmt is more effective than tyrosine in 
scavenging of ROS because bears much structural similarity to vitamin E, indeed 
both have the methylated phenol structure. Zhao and colleagues showed that upon 
induction of oxidative stress by tertbutylhydroperoxide (tBHP), cells treated with 
the SS-peptides decreased levels of mitochondrial reactive oxygen species and 
halted the progression of apoptosis (Zhao et al., 2004). All of SS peptides show 3+ 
net charges at physiologic pH and they are taken up into cells in an energy-
independent non saturable manner. The uptake is really fast, several studies 
showed that SS-20 peptide is taken up into cells in less than 30 minutes and can 
freely pass through the plasma membrane in both directions (Zhao, 2004). The SS-
peptides targeting preferentially the inner mitochondrial membrane, indeed SS-31 
and SS-02 are taken 1000-fold and 10,000-fold respectively, in liver and brain mouse 
mitochondria (Zhaoet al., 2004. Zhao et al., 2005) and concentrate in mitochondria 
1,000-fold more than the cytosolic concentration (Zhao, 2004). The mechanism of 
uptake into mitochondria is not self limiting but how it works is still unclear. During 
uptake of SS-peptides there is not a well defined formation of vesicles, typical of an 
endocytosis uptake. The uptake of these aromatic-cationic peptides is not 
dependent on mitochondrial membrane potential, a study showed that they are 
also concentrated in FCCP depolarized mitochondria (Doughan, 2007). Experience 
has taught us that talking about drug development to cross the blood brain barrier 
(BBB) is the maximum impediment for new drugs. Studies have shown ability of 
SS02 to get mouse brain in 5 minutes after intraventricular injection (Gifford A., 
2004, unpublished data). Between SS-peptides, the short SS-31 peptide developed 
by Szeto is the most promising mitochondria-targeted antioxidants (Zhao, 2004) its 
antioxidant potentialities were confirmed against different types of adverse 
treatments in both in animal (Huang et al., 2013) and in vitro models (Zhao et al., 
2013). A number of studies confirmed the potential applicability of SS-peptides on 
different pathological conditions. Both SS-02 and SS-31 impeded myocardial 
stunning when administered upon reperfusion after 30 minutes ischemia in the ex 
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administered to mice after acute cerebral ischemia (Cho et al., 2005). SS-31 was 
evaluated in animal models of neurodegenerative disease, PD (Yang et al., 2009) 
and Amyotrophic lateral sclerosis (ALS) (Petri et al., 2006). Nowadays, SS-peptides 
are the most promising approach with targeted delivery of antioxidants to 
mitochondrial organelle. Their extraordinarily potent in protecting against oxidative 
cell death is already proven by a number of publications. Moreover, they have an 
excellent pharmacokinetic profile and they are easily “druggable”, small, easy and 
fast to synthesize, readly soluble in water and resistant in human serum until to six 















Name  sequence 
SS-02  Dmt-d-Arg-Phe-Lys-NH2 
SS-20  Phe-d-Arg-Phe-Lys-NH2 
SS-31  d-Arg-Dmt-Lys-Phe-NH2 
SS-19 Dmt-d-Arg-Phe-A2bu-NH2 
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GOAL OF THE THESIS 
 
Mitochondria are subcellular organelles involved in pivotal metabolic cellular 
pathways. Mitochondria developed a special membrane structure and network of 
antioxidant systems to help preserve its functions. A number of studies showed that 
the onset or the exacerbation of many diseases is caused by mitochondrial 
impairment (Szarka et al., 2014). Mitochondrion is an expecially interesting 
organelle for drug therapy given its role in the pathology of cancer, 
neurodegenerative diseases, and other diseases characterized by oxidative stress 
(Weissig et al., 2004). Drugs could be necessary for both inhibiting mitochondria in 
order to kill cancer cells as well as to protect the cells from oxidative damage and to 
repair dysfunctions. Over the years different strategies have been developed in 
order to get access to mitochondria, but its complex structure was often a tough 
hurdle to overcome so gaining access to this organelle could be difficult. Lately, the 
most useful strategy is based on cell penetrating peptide targeting mitochondria. 
Nowadays a novel class of small cell-permeable peptide antioxidants reported a 
great deal of attention. The structural motif of these peptides, named Szeto-Schiller 
peptides (SS-peptide), is characterised on alternating aromatic residue and basic 
amino acids (Szeto, 2006). This thesis was focused on the synthesis of a new short 
cell penetrating antioxidant peptide able to cross cellular membrane and target 
mitochondria. Gaining access to mitochondria means make easier treatments on it. 
The final purpose was to use antioxidant actions of this peptide to protect 
mitochondria against oxidative stress and due of its “druggable” properties use it as 
new tool on drug delivery strategy.  
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MATHERIAS AND METHODS  
 
Solid phase Peptide Synthesis (SPPS) 
 
A Peptide is a chemical compound consisting of amino acids condensed with each 
other through a peptide bond or amide bond between α-carboxyl group of residue 
and the α-amino group of next amino. Peptides have a maximum of 50 amino acids 
(Jones, 1991) and the term protein describes molecules with more than 50 amino 
acids. Peptides have a wide range of applications in medicine and biotechnology, for 
this reason solid phase peptide synthesis (SPPS) plays today a pivotal rule in the 
area of development of new therapeutic strategies, allowing the chemical synthesis 
of peptides and small proteins. SPPS has been used for the first time by Merrified 
(Merrefield, 1973), starting a revolutionary approach to the chemical synthesis of 
polypeptides. The basic principle of SPPS is the stepwise addition of protected 
amino acid to a growing peptide chain bounded by its C-terminal carboxylic acid by 
a covalent bond to a solid, stable and inert resin particle (Fig. 6). By-products and 
excess reagents may be removed easily by filtration and washing. Peptide Synthesis 
starts from Carboxyl-Terminus (COOH-Terminus, or C-terminal end) to Amino-
Terminus (NH2-Terminus, or N-terminal end), adding one by one activated amino 
acids. Activation of the carboxyl component of amino acids is based on formation of 
active esters. The activation makes more electrophilic carboxyl group, because of 
that α-carboxyl group of the amino acids is activeted to facilitate nucleophilic attack 
by the α-amino group of the previously coupled amino acid. Peptide bond is 
assisted by presence of coupling reagents, called also auxiliary nucleophiles. The 
newest coupling reagents belong to uranium and phosphonium salt. The use of 
these reagents has been reported to be more convenient and superior. Some of the 
most commonly used coupling reagents are BOP, PyBOP, TBTU, HBTU, HATU, TFFH, 
PYBrOP, TOTU (Hudson, 1988). Coupling and activation of amino acids are really 
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than amount of resin. Good outcome of reaction depends on availability of only a 
single nucleophile during acylation reaction, therefore is necessary to block those 
functional groups that must not participate in the peptide bond formation. In 
peptide synthesis the α-amino group are protected with temporary protecting 
groups, which are cleaved after each coupling reaction, and the functional groups of 
the amino acid side chains are protected with permanent protecting groups, which 
are cleaved after the synthesis is completed. In SPPS two main strategies are used: 
Boc /Benzyl-based strategy, Fmoc/tert-butyl-based strategy. Tert-butyloxycarbonyl 
(Boc) was first applied in 1950s; this group is stable towards most nucleophiles and 
bases, it is cleaved by acid e.g. Trifluoroacetic Acid (TFA) in Dichloromethane (DCM) 
or others strong acids e.g. HBr in TFA. This strategy is based upon the graduated 
acid lability of the side-chain protecting groups. In Boc/benzyl-based SPPS a number 
of side reactions may be caused by repetitive acid treatments during the synthesis 
and the use of a strong acid for the final deprotection. In order to avoid side 
reactions generated by Boc strategy, a new protocol based on orthogonal 9-
fluorenylmethyl-oxycarbonyl (Fmoc) protecting group was developed by Carpino 
and Han. (Carpino, 1972). The Fmoc group is stable to acid, but is clave by base, e.g. 
piperidine in DMF, or tert-butyloxycarbonyl. Fmoc-based SPPS method is now the 
method of choice for the routine synthesis of peptides. Semi permanent protection 
groups for functional amino acid side chains are removed when synthesis ends. 
There are different protecting group strategies that allow in selecting amino acid 
being protected on the base of amino acids side chains. Cleavage and final 
deprotection are really important steps in peptide synthesis. The cleavage cocktails 
frequently used is a mixture of TFA and scavengers. The SPPS involves numerous 
repetitive steps. After loading the first amino acid, the desired peptide sequence is 
assembled in a linear fashion from the C-terminus to the N-terminus, alternanting 
deprotection and coupling of amino acids until the desired sequence is obtained. 
This technique has made the synthesis of peptides faster: averagely, each amino 
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In a final step, the peptide is released from the resin and the side-chain protecting 













Fig.6. General scheme of solid phase peptide synthesis, SPPS. Adapted from Amblard et 
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Manual Synthesis of MitPep-peptide and SS31 peptide 
 
All the peptides were synthesized manually by solid phase peptide synthesis using 
Fmoc-chemistry protected amino acids and 1,3-diisopropylcarbodiimide (DIC):1- 
(HOBt) as coupling agents (Soomets et al., 2005). SPPS can be performed in classical 
glass reaction vessels that can be made by glassblowers or purchased from 
manufacturers, alternatively syringes equipped with PTFE or glass frits may also be 
used. For the peptide synthesis Fmoc-Rink-Amide-MBHA-resin was usually used. 
Before starting the solid phase synthesis, the resin was swollen in an adequate 
solvent such as DCM or DMF. Couplings were performed with Fmoc-protected D or 
L-amino acids and tree activators 1H-benzotriasole-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (TBTU), N-hydroxybenzotriazole (HOBt) and 
N,N-diisopropylethylamine (DIPEA) in  N,N-dimethyl formamide (DMF) for 45’ each 
coupling (Table. 2), the Fmoc group was removed with piperidine (20% v/v) in DMF 
(20min). The success in each coupling and deprotection step were evaluated by 
qualitative Kaiser test. Typically compared to the resin, 2–10 times excess of 
activated amino acid is used. This excess allows a high concentration of reactants 
(typically 60–200 mM) to ensure appreciable amount of products (Muriel et al., 
2006). The final cleavage from the resin/deprotection of the peptides was 
performed to minimize the by-products formation resulting from Rink amide resin 
at high concentrations of trifluoroacetic acid (TFA). The peptide was deprotected 
from permanent groups and detached from the resin and by adding trifluoroacetic 
for peptide lacking cysteine acid (TFA) 95% (v/v), water 2.5%(v/v), triisopropylsilane 
(TIS) 2,5% (v/v); for peptides containing cysteine or metionine TFA 94% (v/v), water 
2,5% (v/v), 1,2-Ethanedithiol (EDT) 2,5%(v/v), TIS 1% (v/v), both mixture per 100 mg 
of resin. Cleavage and deprotection are one of the crucial steps in peptide synthesis, 
is not a simple reaction, but a series of competing reactions, it takes at least 3 hours 
at room temperature, under gentle stirring. To induce peptide precipitation, the 




Marco Pirisinu, “Rational design and applications of a new Cell-penetrating Peptide 
targeting Mitochondria”. Tesi di Dottorato di ricerca in Neuroscienze XXVII ciclo. Univerità 
degli studi di Sassari 
about 40 ml ether for 3 ml cleavage cocktail, centrifuge at 7000 rpm for 5 minutes. 
Then slowly and carefully ether solution was decanted to a waste container 
avoiding shaking up the precipitate, was repeated two times to get rid of residual 
TFA and scavengers. The crude precipitate was left under fume hood until ether 
evaporated completely. The crude peptide was obtained in solid form through 
lyophilization of the acetic acid extract. A fluorescent analog containing 5,6-









Purifiction of peptides by HPLC and mass evaluation by MALDI-TOFF 
 
The crude peptides were purified by reverse-phase high performance liquid 
chromatography (RP-HPLC) on a BioBasic C-8 column (Thermo Scientific, Sweden). 
The stationary phase was porous silica, covalently bound to a non–polar compound 
such as octadecyl silane (C18) or octysilane (C8). The convenient mobile phase for 
the separation of peptides was a gradient elution system where the composition of 
the solvent was continuously changed by a gradient programmer. All solvents used 
in HPLC systems must be of specific grade to keep save column and allow the use of 
a highly sensitive detection system. Routinely the crude peptides were purified 
employing an acetonitrile (ACN)/water mixture with a gradient of 0.1% TFA. Crude 
Compound  MW Equivalents mmol 
Peptide resin  1 0.065 
Fmoc-amino acid  4 0.26 
HCTU,0.5M in DMF  413.17 4 0.26 
6-Cl-HOBt 0.5M in NMP 169.57 4 0.26 
DIPEA, 5.84M neat 129.3 8 0.52 
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peptide was lyophilized, briefly, to dilute the correct peptide fraction in few 
millilitres of MQ water and freeze at -80°C for 24 h, then make holes into the cap of 
the tube with a syringe needle. Thereafter the tube of freezed peptide with solution 
was put into vacuum machine overnight. Each peptide was at least 98% pure as 
assessed by analytical reversed-phase HPLC. Molecular mass of peptides was 
determined by a matrix–assisted laser desorption/ionization time-of-flight mass-
spectrometry (MALDI–TOFF) (Voyager-DE STR, Applied Biosystems), the values were 
compared with theoretical mass. According to the Applied Biosystems guidelines, 
saturated solution of α-cyano-4-hydroxycinnamic acid was chosen for the matrix (10 
mg/ml in 50:50 ACN/water mix with 0.1% TFA content). MALDI is an ionization 
technique based. In this technique the sample is crystallized together with a matrix 
which is irradiated by a UV–laser beam. The matrix is ionized by the laser and some 
of its charges achieve the analyte, generating molecular ions of the analyte, in the 
same time protecting it from direct ionization by the laser. The time of flight 
detector evaluates the spent time for the analyte ion to reach a detector at known 
distance. This time depends on the mass-to-charge ratio of the particle and might 




HeLa 705, cervical human cellular line was chosen to evaluate biological effects and 
uptake of MitPep. HeLa cells are important tool on biological science and medical 
research, they are the first immortal human cells ever grown in culture, many 
scientific landmarks since then have used HeLa cells, including cloning (Leid et al., 
1992), gene mapping (He et al., 2014), in vitro fertilization (Ashizawa et al., 1992), 
drug delivery strategy (Bracht et al., 2014). HeLa 705 cells (human cervical cancer 
cell line) were cultured as subconfluent monolayers in 75cm2 cell culture flask. HeLa 
705 in Dulbecco's Modified Eagle Medium (DMEM) (lifetechnologies) supplemented 
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1% Penicillin-Streptomycin (life technologies), kept in a humidified incubator at 37o 
C, 5% CO2. Cells grown to subconfluence were enzymatically dissociated from the 
surface with a solution of 0.05% trypsin/0.53mM EDTA 
(ethylenediaminetetraacetic). To evaluate viability, mitochondrial membrane 
potential and ROS production, cells were plated at 1 X104 cells/well in 96 well plates 
24h prior to the experiment. To isolate mitochondria 7X106 cells were plated in 275 
cm2 cell culture flask 3 days prior to experiment. For cellular uptake experiments 
and microscopy studies cells were plated at 7,5X104 cells were plated in glass 
bottom disches. For fluorescence studies was used a fluorescent analog FAM-MIP1 
conjugated. 
 
Cell viability assay 
 
Cell viability was determined by conventional WST-1 assay (Roche Diagnostics 
Scandinavia AB, Sweden). WST-1 reagent is designed to be used for the 
quantification of cell proliferation using 96 well-plate format, it is a colorimetric 
assay based on reductases activity of mitochondrial succinato deidrogenase. A 
tetrazolium salt is reduced to formazan dye by active mitochondria, the amount of 
dye is correlated to the number of cell with active succinato deidrogenase. Briefly, 
HeLa 705 cells were plated at a density 1X104 cells/well in 96-well plates and 
allowed to grow for 24 h before treatment with MIP1. The concentration of MIP1 
stock solution was 1 mM in MilliQ water, different working solutions were 
prepared. Cells were treated at the final concentrations 0.5-5-50-100 μM in 100 μl 
of complete medium for 24 h and H2O2 200 μM for 24h was used as positive 
control. Cell proliferation reagent WST-1 was added to each well at final dilution 
1:10, in this case 10μl/100μl. After 4 h incubation the absorbance was measured at 
450 nm on Sunrise microplate absorbance reader (Tecan, Switzerland). The same 
assay was performed in order to evaluate the viability after H2O2 treatment. Briefly, 
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two different hydrogen peroxide conditions: treatment of MIP1 for 30’ or 2 h before 
to receive H2O2 200 μM, then kept in a humidified incubator at 37
o C, 5% CO2 for 24 
h. Cell proliferation reagent WST-1 was added to each well as described above, after 
4 h substrate reaction the absorbance was determined at 420 nm. Cell viability of 
treated cells was expressed as a percentage of the viability of cells MIP1 or H2O2 
untreated. 
 
Mitochondrial membrane potential assay 
 
Mitochondrial membrane potential was evaluated using the fluorescent probe 
TMRE (tetramethylrhodamine methyl ester) (TMRE, mitochondrial potential 
membrane, assay kit. Abcam). TMRE is a cell permeant, positively-charged, red-
orange dye that readily accumulates in active mitochondria due to their relative 
negative charge. Depolarized or inactive mitochondria have a reduced 
mitochondrial membrane potential and fail to sequester TMRE. Briefly, HeLa 705 
cells were plated in 96 well plates 24h prior to receive treatments. The day after 
cells were treated with MIP1 for 24h at the same concentrations described above, 
H2O2 200 μM was used as positive control. Cells were loaded with TMRE 400 nM 
and were kept at 37°C-5% CO2, protected from light. After 30’ of TMRE staining, 
media was aspired and cells were washed once with 0.2% BSA in normal PBS to 
remove background fluorescence from the culture media, 100μL/well of 0.2% BSA 
in normal PBS was added. The plate was read on a fluorescence reader with settings 
suitable for TMRE (more details see below). The same assay was performed in order 
to evaluate the ability of MIP1 to restore a normal mitochondrial membrane 
potential after insult of H2O2. Briefly, HeLa 705 cells were plated and treated with 
MIP1 at the same concentrations described above, after 2 h cells were insulted by 
H2O2 200 μM, kept for 24 h of incubation at 37°C-5% CO2. TMRE was added to each 
well at concentration described above. After30’, media was aspired and cells were 
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BSA in normal PBS. Semi-high throughput screening (HTS) fluorescence reader 
(FlexStation II, Molecular Devices) was used and Fluorescence at 518/580 (ex/em) 
was registered in order to measure the production of ROS by mitochondria. 
Fluorescence at 549/575 (ex/em) (TMRE-tetramethylrhodamine, ethyl ester) was 
registered for interrogating mitochondrial membrane potential in live cells. ΔΨm 
polarizations were observed on increasing TMRE relative fluorescence unit, and 
decreasing TMRE relative fluorescence unit were associated to depolarization. After 
an initial 20 seconds baseline recording, 10 µl of reference chemical dilutions 
(prepared at 10 times the final well concentration) was transferred automatically by 
the FlexStation II to plate wells (6 wells per reference chemical concentration) and 
fluorescence was read for another 220 seconds. The mean of the values from the 
baseline recording was set to zero, and the size of CMP change was quantified as 
area under the curve, using the SoftMax® Pro 4.8 software (Molecular Devices). 
Mitochondrial membrane potential on treated cells was expressed as a percentage 
of the mitochondrial membrane potential on untreated cells or H2O2 treated cells. 
 
ROS production assay 
 
Mitochondria’s ROS production was measured by fluorescent probe MitoSOX Red 
mitochondrial superoxide indicator (Invitrogen Detection technologies). MitoSOX 
Red reagent is rapidly and selectively targeted to the mitochondria. Once in the 
mitochondria, MitoSOX Red reagent is oxidized by superoxide and exhibits red 
fluorescence (Invitrogen Detection technologies). As manufacture protocol 
suggests, one vial of MitoSox reagent was dissolved in 13 μL of dimethylsulfoxide 
(DMSO) to make a 5 mM MitoSOX reagent stock solution, the 5 mM MitoSOX 
reagent stock solution (prepared above) in HBSS/Ca/Mg to make a 5 μM MitoSOX 
reagent working solution. Briefly, HeLa 705 cells were plated in 96 well plates 24h 
prior to receive treatments. The day after cells were treated with FAM-MIP1 for 24 
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5 μM and were kept for 10’ of incubation at 37°C-5% CO2, protected from light. 
After MitoSOX staining, media was aspired and cells were washed once with 0.2% 
BSA in normal PBS to remove background fluorescence from the culture media, 
100μL/well of 0.2% BSA in normal PBS was added. The plate was read on a 
fluorescence reader (more details see below). The same assay was performed in 
order to evaluate the ability of MIP1 to save normal levels of ROS in insulted cells by 
H2O2. Briefly, HeLa 705 cells were plated and treated as described above. After 2 h 
treatment of MIP1, cells were insulted by H2O2 200 μM and kept for 24 h of 
incubation at 37°C-5% CO2. MitoSOX was added to each well at concentration 
described above. After 10’, media was aspired and cells were washed once with 
0.2% BSA in normal PBS and replaced with 100μL/well of 0.2% BSA in normal PBS. 
The absorbance was measured by fluorescence reader. Semi-high throughput 
screening (HTS) fluorescence reader (FlexStation II, Molecular Devices) was used 
and Fluorescence at 518/580 (ex/em) was registered in order to measure the 
production of ROS by mitochondria. Fluorescence at MitoSOX (Ex: 510nm, Em: 
580nm) was registered for interrogating levels of ROS in live cells. More amount of 
ROS were observed on increasing MitoSox relative fluorescence unit, and 
decreasing MitoSox relative fluorescence unit were associated to decreased oxidant 
species. After an initial 20 seconds baseline recording, 10 µl of reference chemical 
dilutions (prepared at 10 times the final well concentration) was transferred 
automatically by the FlexStation II to plate wells (6 wells per reference chemical 
concentration) and fluorescence was read for another 220 seconds. The mean of 
the values from the baseline recording was set to zero, and the size of CMP change 
was quantified as area under the curve, using the SoftMax® Pro 4.8 software 
(Molecular Devices). Amount of fluorescence in treated cells was expressed as a 
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Measurement of mitochondrial uptake of (FAM) 
5(6)carboxyfluorescein-MIP1 conjugated on isolated mitochondria 
 
In order to evaluate mitochondrial uptake of MIP1, mitochondria from HeLa 705 
cells were extracted following the instruction of Mitochondria Isolation Kit for 
cultured cells (Thermo Scientific, Pierce, USA). It was essential to start with an 
appropriate amount of cultured cells to obtain a visible and experimentally 
manageable pellet of the mitochondrial fraction. Briefly, according to the method 
by Zhao K. et al. (Zhao et al., 2004) for uptake study isolated mitochondria from 20 
106 cells were incubated in 0.3 ml buffer (10 mM TrisHCl pH 6.7, 0.15 mM MgCl2, 
0.25 mM sucrose, 1 mM Phenylmethanesulfonyl fluoride (PMSF), 1 mM 
Dithiolthreitol (DTT) containing 5 μM of fluorescent polyanionic probe FAM-
conjugated to MIP1, time of treatments was 4 h at RT. Uptake was stopped by 
centrifugation (12,000 X g for 5’ at 4° C), the mitochondrial pellet was washed twice 
and resuspended in 0.3 ml of phosphate buffered saline (PBS). Mitochondrial 
suspension was split into three rates, 100µl volume each and transferred in 96 
plates black well. Mitochondrial uptake of FAM was determined using same 
procedure. Fluorescence at 494/519 nm (ex/em) (FAM) was registered every 
2 seconds in a semi-high throughput screening (HTS) fluorescence reader 
(FlexStation II, Molecular Devices) to quantifying the peptides into the cells or into 
the isolated mitochondria. After initial 20 seconds baseline recording, 10 µl of 
reference chemical dilutions (prepared at 10 times the final well concentration) was 
transferred automatically by the FlexStation II to plate wells and fluorescence was 
read for another 220 seconds. The mean of the values from the baseline recording 
was set to zero, and the size of CMP change was quantified as area under the curve, 
using the SoftMax® Pro 4.8 software (Molecular Devices). Amount of fluorescence 
in FAM-MIP1 complex treated cells was expressed as a percentage of the amount of 
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Cellular uptake and intracellular localization of MIP1 Peptide 
 
FAM-MIP1 uptake in HeLa 705 cells was carried out as previously described (Zhao et 
al., 2004). Cells were incubated with FAM labeled MIP1 (5 μM) for 4 h at 37° C and 
imaging was performed. In order to identify MIP1 intracellular localization, a final 
concentration of 5 μM FAM labeled MIP1 or SS31 was incubated with HeLa 705 cells 
for 4 h at 37° C. To demonstrate mitochondrial localization, TMRE (100 nm) 
mitochondrial dye was added to the medium 4 h after and nuclear dye Hoechst 
33358 (50 nm) 15’ after TMRE. The cells were washed three times with PBS. Imaging 
was performed on living cells using Leica DM/IRBE 2 epi-fluorescence microscope 
controlled by micro manager (Edelstein et al., 2010) with a 63 × 1.4 NA oil 
immersion objective. Emission were collected between 494 and 519 nm (FAM-5(6)-
Carboxyfluorescein), 549 and 575 nm (TMRE red fluorescence), 352 and 461 nm 
(Hoechst 33358-Pentahydrate (bis-Benzimide). Cells were manually segmented and 
region intensities were quantified using Fiji (ImageJ) (Schindelin et al., 2012). 
 
Statistical Analisys  
 
All data were expressed as mean ± standard deviation. Statistical analyses were 
performed using GraphPad Prism software v. 5.00. Comparisons between two 
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RESULTS 
 
Design of MIP1 peptide  
 
Using the solid-phase synthesis protocol described above, a new short peptide was 
synthesized. MIP1 is a tetrapeptide, its sequence was designed to display at least 
three characteristics known as important to targeting mitochondria: positive 
charge, lipophilic character and alternating aromatic residues and basic amino acids. 
The release of protons from the mitochondrial matrix to the intermembrane space 
generates a negative potential (-150/-180Mv) in mitochondrial inner membrane 
(Dai et al., 2014). The negative potential works as attractive point on the use of 
lipophilic cations to deliver redox agents into mitochondrial matrix. Lipophilicity is 
an important condition in order to obtain selective peptide targeting mitochondrial 
and to allow partitioning of the peptides through the lipid bilayer (Rosania, 2003). It 
was suggested by Zhao and colleagues (Zhao et al., 2004) that alternating aromatic 
and cationic residues indicate that this motif is an effective one for mitochondrial 
delivery. The synthesis of MIP1 was carried out after evaluation of data previously 
published in this field (Horobin, 2007. Szeto, 2006) and the following rules were 
kept : 
1. tyrosine (tyr) or dimethyltyrosine (Dmt) residues in the first or second 
position of sequence to increase antioxidant activity. 
2. D-amino-acid in either the first or second position to minimize 
aminopeptidase degradation and increase stability in serum. 
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Effects of MIP1 peptide on the cell viability of HeLa 705 cells  
 
The toxic effect of MIP1 peptide was evaluated on HeLa 705 cells using conventional 
WST-1 assay (figure. 7-A). Different concentrations of MIP1 were chosen as 
treatment (0.5-5-50-100 μM). Viability was calculated after 24h of MIP1 incubation 
and H2O2 200 μM for 24h was chosen as positive control. MIP1 did not show toxic 
effects on viability of HeLa 705 cells at concentrations used even at higher used 
concentration (100 μM) viability was still around 90% compared to non treated 
cells; on the contrary positive control group showed 35% of decreased viability in 
comparison with no treated cells. The same viability assay was used to appreciate 
eventual protective effect of MIP1 against H2O2 damage. HeLa 705 cells received 
MIP1 pretreatments at the concentrations described above, after 30’ or 2h they 
were insulted by H2O2 200 μM. Hydrogen peroxide resulted in a significant 
reduction of cell viability but in pretreated cells H2O2 damage was decreased by 
antioxidant activity of MIP1. Protective effects were seen with MIP1 doses of 0.5 
and 5 μM. As shown in figure 7-B, hydrogen peroxide treatment reduced cell 
viability up to 77% compared to control group, pre-treatment of 30’ with MIP1 at 
0.5 and 5 μM restored it at 85%. Cell viability was restored at 90% after 2h 
pretreatment of MIP1 with dose of 5 μM. MIP1 showed protective action from 0.5 
to 5 μM, on the contrary high used concentration did not show defensive properties 
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Fig.7. Effect of MIP1 peptide (0.5-5-50-100 μM) on HeLa 705 cells viability in absence or presence of 
hydrogen peroxide. Cell viability was quantified by conventional WST-1 assay 
(A). HeLa 705 cells were treated with MIP1 for 2 h, H2O2 200 μM was chosen as positive control of toxicity, 
MIP1 treatments did not show toxicity on HeLa 705 cells. *p < 0.05 compared to MIP1 0μM (B) HeLa 705 
cells were treated as the same concentrations described above, H2O2 200 μM insult was added 30’ or 2h 
after MIP1 treatments. Pretreatment with MIP1 (0.5-5 μM) attenuated the reduction in cell viability. 
Maximum protection was seen in cells pretreated with MIP1 at 5 μM 2h before H2O2 200 μM.*p < 0.5 
compared to MIP1 0 μM. § p < 0.05 compared to MIP1 0 μM 2h before H2O2 200 μM 
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Effects of MIP1 peptide on mitochondrial membrane potential of 
HeLa 705 cells 
 
Mitochondrial membrane potential was determined by fluorescent probe TMRE, 
HeLa 705 human cervical cancer cell line was chosen as cellular model. Eventual 
membrane potential impairment was evaluated after 24h treatments of MIP1 
peptide (0.5-5-50-100 μM); H2O2 200 μM for 24 h as positive control of toxicity was 
used to obtain a significant membrane depolarization. Results showed that 
treatments of MIP1 did not perturbed mitochondrial membrane potential. 
Mitochondrial membrane potential after MIP1 treatments at 0.5 and 5 μM was 
between 80 and 95 % of the control value. On the other hand cells treated with 100 
μM of MIP1showed a significant reduction of mitochondrial membrane potential 
(Fig. 8.). To demonstrate that reduction in mitochondrial generated ROS can protect 
against mitochondrial dysfunction, was examined the effect of MIP1 on 
mitochondrial depolarization-H2O2-induced. Hydrogen peroxide caused a 
depolarization of mitochondrial potential 45 % of Δψm compared to control. 
Pretreatments of MIP1 at 0.5 and 5 μM showed a significant increasing of 
fluorescence intensity compared to value of hydrogen peroxide fluorescence. In 
particular, pretreatment of MIP1 at 5 μM, maintained a potential up to 92% of 
control value (MIP1 0 μM). Concentrations of MIP1 at 100 μM did not show 
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Fig.8. Effect of MIP1 peptide (0.5-5-50-100 μM) on HeLa 705 cells mitochondrial membrane 
potential in absence or presence of hydrogen peroxide. Mitochondrial membrane potential was 
quantified by the fluorescent probe TMRE 
MIP1 24 h treatments did not perturb mitochondrial membrane potential on HeLa 705 cells. (first bar 
of each group). In the second bar of each group H2O2 200 μM treatment was added 2h after MIP1 
treatments. Pretreatment with MIP1 (0.5-5 μM) preserved a normal mitochondrial membrane 
potential. Maximum protective action was seen in cells pretreated with MIP1 at 5 μM 2h before H2O2 
200 μM.*p < 0.5 compared to Mip1 at 0μM. § p < 0.05 compared to MIP1 at 0 μM 2h before H2O2 200 
μM 
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Effects of MIP1 peptide on ROS production in HeLa 705 cells 
 
Reactive Oxygen species (ROS) production was determined using fluorescent probe 
MitoSOX Red mitochondrial superoxide indicator. HeLa 705 human cervical cancer 
cell line was chosen as cellular model. Eventual ROS production was analyzed after 
24h treatments of MIP1 peptide (0.5-5-50-100 μM); treatments of H2O2 200 μM for 
24 h were used as positive control. In order to evaluate an eventual antioxidant 
activity, cells were pretreated with MIP1 for 2 h then H2O2 200μM was added for 
24h. H2O2 treatment increased ROS production up to 135% of control value (Fig. 9), 
lower mitosox fluorescent intensity was appreciated in MIP1 at 0.5 and 5 μM 
pretreated group. In particular, treatments of MIP1 0.5 μM and 5 μM decraesed of 
10% and 20% the MitoSox fluorescence intensity compared to H2O2 treatment. 
Higher concentrations of MIP1 showed a decreasing protective action, 50 and 100 
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Fig. 9. Effect of MIP1 peptide (0.5-5-50-100 μM) in ROS production on HeLa 705 cells in absence or 
presence of hydrogen peroxide. ROS production was quantified by fluorescent probe MitoSOX Red 
mitochondrial superoxide indicator  
MIP1 treatments 24 h did not increase amount of ROS on HeLa 705 cells (first bar of each group). In the 
second bar of each group H2O2 200 μM treatment was added 2h after MIP1 treatments. Pretreatment 
with MIP1 (0.5-5 μM) preserved aa amount of ROS near to value on non treated cells. Maximum 
protective action was seen in cells pretreated with MIP1 at 5 μM 2h before H2O2 200 μM 
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MIP1 cellular uptake and localization  
 
To demonstrate that MIP1 is cell-penetrating peptide, it was conjugated to 5,6-
carboxyfluorescein (FAM). HeLa 705 cells were treated with FAM-MIP1 (5 μM) and 
incubated for 4 h at 37°C, then imaging was performed using fluorescence 
microscopy. MIP1 was taken up into HeLa 705 cells after 4 h of treatment. In order 
to verify the ability of the peptide to target the mitochondria a red fluorescence 
dye, tetramethylrhodamine, ethyl ester (TMRE) that specifically localizes into active 
mitochondria was used. In order to compare the cellular localization between the 
original peptide and the new one Hela 705 cells were treated also with FAM-SS31. 
As shown in Figure 10, Leica DM/IRBE 2 epi fluorescence microscope captured 
identical patterns in HeLa 705 cells when TMRE, FAM-MIP1 were co-incubated, as a 
proof that MP1 is targeting mitochondria. In order to compare the cellular 
localization between the original peptide and the new one, HeLa 705 cells were 
treated also with FAM-SS-31. Afterwards, the cellular localization of FAM-MIP1 was 
compared with FAM-SS31 one, the original peptide. The SS31 peptide was used as 
model of CPPs targeting mitochondria. The evaluation of relative fluorescence of 
both MitPep and SS31 showed similar intracellular distribution. Moreover HeLa 705 
cells taken up more FAM-MIP1 than FAM-SS31 as shown in the microscopy picture 
(Fig. 10) and confirmed from the relative quantification based on the fluorescence 
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 Fig.10 . Fluorescence image of cellular uptake and localization of MIP1 and SS-31 on HeLa cells 
HeLa cells were treated with FAM-MIP1 (A, B, C) or FAM-SS-31 (D; E; F) at 5μM, (green fluorescence). After 
4 H cells were counterstained with mitochondrial dye, TMRE (red fluorescence) and nucleus dye, Hoechst 
33258 (blue fluorescence). Merged images (C) shows co-localization of TMRE and FAM-MIP1 fluorescence, 
proving that MIP1 is targeting mitochondria. The evaluation of relative fluorescence of both MIP1 and 
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Mitochondrial uptake of MIP1 
 
Mitochondrial uptake of MIP1 was examined using isolated mitochondria. In this 
study, isolated mitochondria were treated with MIP1 conjugated with FAM for 4 
hours at 5 μM. FAM alone was used as a positive control at the same concentration. 
After 4 h of treatment the fluorescence was read with a spectrofluorometer. 
Relative FAM fluorescence intensity was associated to the amount of peptide 
conjugated with FAM or FAM alone inside the mitochondria. Isolated mitochondria 
treated with FAM-MIP1 showed higher fluorescence intensity, statistically 
significant in comparison to FAM mitochondria treated. In mitochondria FAM-MIP1 
treated group the intensity of fluorescence was eight times higher than FAM 
treated group. (Fig. 12) 
Fig. 11. FAM relative fluorescence intensity 
Graphs show relative fluorescence of FAM-MIP1 and FAM-SS31 in HeLa 
cells. After 4 h treatments intensity was more on FAM-MIP1 treatment than 
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Fig. 12. FAM Fuorescence intensity on isolated mitochondria.  
Black bar shows FAM relative fluorescence in isolated mitochondria, Blue bar relative fluorescence in 
FAM-MIP1 conjugated treated mitochondria.*p < 0.05 compared to FAM fluorescence intensity.  















Marco Pirisinu, “Rational design and applications of a new Cell-penetrating Peptide 
targeting Mitochondria”. Tesi di Dottorato di ricerca in Neuroscienze XXVII ciclo. Univerità 
degli studi di Sassari 
DISCUSSION AND CONCLUSION 
 
Nowadays is known that mitochondrial impairment results in over ROS productions 
and this gave rise to onset or to exasperation of diseases characterized by different 
clinical symptoms. Sometimes antioxidants may be harmful because need really 
high dose supplementation to get specific target resulting in prooxidant effects 
(Steinhubl. 2008). Mitochondrial ROS are generated as normal byproducts of 
oxidative metabolism. Approximately 3% of mitochondrial oxygen consumed is 
incompletely reduced (Gauuan et al., 2002); those “leaky” electrons can easily 
interact with molecular oxygen to generate ROS such as superoxide anion (Tieu et 
al., 2003). This knowledge increased exponentially the number of studies on 
mitochondrial functions and resulting in a wide range of strategies to develop 
mitochondrial targeted antioxidants and drugs delivery strategies into this 
compartment. To this day a range of natural and synthetic molecules showed great 
antioxidant activity in in vitro studies, but do not proved to be particularly effective 
in clinical trials, of these VitE (Miller et al., 2005), turmeric (Kaminaga et al., 2003) 
This limit could be due to physical and chemical characteristics that obstruct 
antioxidants to reach the relevant sites of free radical generation. CPPs are one of 
the most widely used and effective drug delivery strategies applicable on basic 
research and medical trials. Nowadays this strategy is drawing more and more 
attention and many studies have been come out characterizing and developing new 
classes of CPPs enlarging their applicability window as in medicine as in biological 
tools. This thesis is focused on mitochondrial target antioxidants peptides. The main 
characteristics of CPPs targeting mitochondria has been spread in 2006 (Sheu et al., 
2005) then increasingly new CPPs went out. In 2000 a new class of cell penetrating 
antioxidant peptides targeting mitochondria was synthesized by Szeto and 
coworkers (Schiller et al., 2000). At today, a number of publications showed and 
confirmed SS-peptides as the most promising tool applicable in the treatment of all 
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neurodegenerative diseases. In this dissertation a new short carrier antioxidant 
peptide target mitochondria, denominated as MIP1, was designed, manually 
synthesized taking SS-31 peptide as reference model. At today there are not CPPs 
sequence less than four amino acids long and MIP1 is a tetrapeptide, water soluble 
and showing positive net charge. Sequence of MIP1 was designed following rules 
and experiences found in literature and displaying two important properties for 
crossing both the plasma and mitochondrial membranes: positive charge and 
lipophilic character. To evaluate toxic effects of MIP1 peptide, HeLa 705 human 
cervical cancer cells were chosen as cellular model. Interestingly, MIP1 did not 
exhibit toxicity even at 100μM. In order to evaluate eventual antioxidant activity an 
oxidative condition was generated using hydrogen peroxide. In absence of efficient 
antioxidant systems, H2O2 can react with transition metals such as ferrous iron, 
which is disproportionately increased during neurodegenerative diseases (Dusek et 
al., 2014). That reaction, named Fentom’s reaction, leading to the formation of the 
highly reactive hydroxyl radical. Large amount of hydroxyl radical has been 
implicated in several pathological conditions (Antus et al., 2014). This radical can 
react and oxidize all types of cellular macromolecules: carbohydrates, nucleic acids, 
lipids and amino acids (Reiteher et al., 1995). At to date, antioxidant systems 
protecting hydroxyl radical has not been known yet; hence, the prevention of its 
formation is a critical anti oxidant process (Sheu et al., 2006). MIP1 showed great 
antioxidants properties at 0.5 and 5μM, more activity was appreciated on 2h pre 
treated cells, suggesting a time dependent mechanism of uptake. The scavenger 
ability was further confirmed by studies on mitochondrial membrane potential and 
ROS production. Antioxidant peptide MIP1 was able to decrease mitochondrial 
depolarization and overload of ROS production in exposed cells to H2O2. On the 
other hand, the higher concentrations of MIP1 totally lost antioxidant capacity. An 
explanation could be that the uptake of MIP1 is self-limiting and it is reduced at 
greater concentration than 50μM. Moreover, MIP1 get net positive charge then, 
limited uptake is may be a consequence of inevitable mitochondrial depolarization 
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shown in literature (Roy et al., 2008), loss of mitochondrial membrane potential 
and oxidative stress are part of vicious circle that give rise to increased 
mitochondrial permeability transition. In view of the above, MP1 results showed 
gradually increased of ROS at the same time decreased mitochondrial membrane 
potential. The sequence of MIP1 is focused on alternating aromatic residues and 
basic amino acids (aromatic cationic peptides) and the antioxidant activity can be 
assigned to Dmt in second positions. Amino acid Tyrosine could scavenge 
oxyradicals forming relatively unreactive tyrosyl radicals, which can be followed by 
radical-radical coupling to give dityrosine or scavenging by glutathione and/or 
ascorbate (Pichorner et al., 1995). Zhao and coworkers demonstrated that, due to 
methylation of the phenolic ring, no natural amino acid Dmt holds more antioxidant 
properties than Tyrosine (Zhao et al., 2004). MP1 is easily water soluble and quickly 
goes through cellular membrane. The uptake of MIP1 has not been studied yet, but 
showing net charge 3+ could make use of the potential gradient across the 
mitochondrial inner membrane to get into mitochondrial organelle. As showed by 
Zhao and co-workers (Zhao et al., 2004), the uptake of SS-peptides were decreased 
by only 10% to 15% in mitochondria that were depolarized by FCCP (carbonyl 
cyanide 4-(trifluorometoxy) phenylhydrazone), then being MIP1 based on SS-31 
sequence could be fairly supposed a similar way to get inside cell. Fluorescence 
microscopy confirmed rapid uptake of a fluorescent MIP1 analog in living cells. The 
intracellular distribution pattern of the fluorescent MIP1 analog was identical to 
Mitotracker TMRE, a fluorescent dye that is taken up into active mitochondria in a 
potential-driven manner, suggesting that MIP1 peptide is targeted to mitochondria. 
In this study SS-31- Szeto-Schiller peptide was taken as reference model. Literature 
is plenty of publications about SS-31 ability to target mitochondria and is 
concentration in mitochondria is 1000 fold more than cytosol compartment (Zhao 
et al., 2004). As shown in the fluorescence microscopy and the relative 
quantification based on the fluorescence intensity, the amount of MIP1 into the 
cells was more than reference model SS-31 underlining its great potentialities as 
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membrane and accumulate into mitochondria was confirmed by uptake study on 
isolated mitochondria. In order to evaluate mitochondrial uptake, MIP1 was 
conjugated to membrane impermeant dye FAM. MIP1 peptide was totally taken up 
within 4 hours by isolated mitochondria confirming this organelle as one of 
potential targets of MIP1. Moreover, the higher relative fluorescence FAM-MIP1 on 
isolate mitochondria underlines the ability of MIP1 to make easier delivering of 
molecules inside specific compartments. Potentially, MIP1 peptide could be 
conjugated with different cargoes to be used as a mitochondrial delivery machine 
for mitochondrial diseases treatment. In summary, MIP1 is cell-permeable peptide 
antioxidants that accumulate into the major site of ROS production and prevents 
mitochondrial impairments. MIP1 was great in reducing intracellular ROS and 
preventing cellular death with less than 5μM concentration, in contrast most 
antioxidant require 100μM to millimolar concentrations to prevent oxidative cell 
death (Pias et al., 2003). MIP1 is a small peptide; fast and easy to synthesize, it is 
completely soluble in water and able targeting mitochondria without toxicity, 
moreover showed antioxidant property and is potentially conjugable to different 
molecules. In view of all these characteristics MIP1 should be taken as hopeful 
candidate against oxidative stress and it could be beneficial as mitochondrial 
delivery drugs machine for making easier treatment of diseases characterized by 
mitochondrial impairment. The ability to target mitochondrial organelles creates 
new opportunities to study physiological and pathological processes at the 
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SUMMARY IN ITALIAN 
 
L’insorgenza e il peggioramento di un’ampia schiera di malattie, tra cui malattie 
cardiocircolatorie, neurodegenerative, diabete e neoplasie sono associati 
all’eccessiva produzione di radicali liberi dell’ossigeno (ROS) (Hroudová 2014). I 
ROS sono molecole altamente instabili che si formano all’interno dei 
compartimenti cellulari in seguito a reazioni endogene enzimatiche e non 
enzimatiche. Numerosi studi hanno dimostrato che la fisiologica presenza 
intracellulare di ROS non è di per se una condizione dannosa, infatti sono 
implicati in fondamentali processi cellulari come autofagia, comunicazione e 
difesa immunitaria (Chen, 2007. Niess, 1999). L’inizio della compromissione 
cellulare è legata ad uno squilibrio spaziotemporale tra produzione di ROS e 
difese antiossidanti, generando una condizione nota come stress ossidativo 
(Zamzami et al., 1997). In assenza di difese antiossidanti, i ROS possono 
potenzialmente reagire con diversi substrati cellulari come proteine, lipidi, 
carboidrati e DNA, provocandone alterazione strutturale, danneggiamento e 
perdita delle normali funzionalità. La letteratura scientifica presenta numerose 
pubblicazioni riguardanti il ruolo principale dei mitocondri nella produzione di 
ROS. Circa il 90% dell’ossigeno richiesto da una cellula, è utilizzato per sostenere i 
fisiologici processi metabolici mitocondriali (Chance, 1979). L’O2 molecolare 
rappresenta l’accettore finale degli elettroni con la sua conseguente riduzione ad 
acqua, tuttavia non tutto l’ossigeno è completamente ridotto, infatti circa il 2% 
dell’anione superossido origina da un’incompleta riduzione dell’ossigeno 
(Chance, 1979). Sviluppare antiossidanti o molecole con specifico target 
mitocondriale è la strategia di scelta per contrastare lo stress ossidativo, e allo 
stesso tempo crea nuove opportunità per studiare i numerosi processi biologici 
che hanno luogo a livello mitocondriale sia in condizioni fisiologiche sia 
patologiche. Nel 2000 è stata sintetizzata una serie di sequenze tetrapeptidiche, 
SS-peptide, dotate di attività antiossidante in grado di accumularsi 
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esperimenti in vivo ed in vitro candidano SS-peptide come futuro promettente 
approccio per il trattamento delle disfunzioni mitocondriali causate da stress 
ossidativo. In questa tesi, prendendo come modello di riferimento SS-31 peptide, 
il più promettente tra le sequenze SS-peptide, un nuovo tetrapeptide, MIP1, è 
stato disegnato e sintetizzato. Gli effetti biologici e la localizzazione di MIP1 sono 
stati valutati su linea cellulare HeLa 705. In seguito ad un ampio screening, MP1 
non ha mostrato alcuna tossicità anche ad alte concentrazioni, non ha 
perturbato il potenziale di membrana mitocondriale e non ha aumentato la 
produzione di ROS. In seguito ai promettenti risultati precedenti è stato deciso di 
valutare l’eventuale attività antiossidante di MIP1. Le cellule sono state 
pretrattate con MIP1, dopo 30 minuti o 2 h sono state trattate con perossido 
d’idrogeno. I risultati hanno evidenziato nei pretrattamenti di 2 h a 0.5 e 
soprattutto a 5μM un’interessante attività antiossidante in grado di proteggere 
le cellule dal danno indotto dal perossido d’idrogeno. In seguito ai risultati 
precedenti, si è deciso di utilizzare per gli studi di microscopia la concentrazione 
5μM. Grazie all’utilizzo di un analogo di MIP1 coniugato con il fluorocromo 5(6)-
carboxyfluoresceina (FAM) sono stati condotti studi di miscroscopia in 
fluorescenza con lo scopo di identificare la localizzazione intracellulare. 
Utilizzando Tetramethylrhodamine methyl ester (TMRE) mitochondrial dye e SS-
31 peptide come indicatori mitocondriali, è stato possibile identificare i 
mitocondri come potenziale target di MIP1. Grazie alla quantificazione della 
fluorescenza relativa di FAM, è stato possibile dedurre che MP1 possiede una 
maggior capacità di localizzarsi all’interno dei mitocondri rispetto al modello di 
riferimento SS-31 peptide. Al fine di valutare le potenzialità di MP1 come carrier, 
sono stati condotti esperimenti su mitocondri isolati. La quantificazione della 
fluorescenza di FAM ha dimostrato una maggior facilità di attraversamento delle 
membrane mitocondriali quando coniugato a MIP1. In conclusione, MIP1 è un 
nuovo tetrapeptide con target mitocondriale. Le sue eventuali proprietà 
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danno ossidativo, inoltre potrebbe essere impiegato come carrier per facilitare, a 
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